HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathleen M Carroll Selected Research

Cocaine-Related Disorders (Cocaine Addiction)

1/2019Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use.
1/2019fMRI Stroop and behavioral treatment for cocaine-dependence: Preliminary findings in methadone-maintained individuals.
1/2018Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial.
1/2018Drug Stroop: Mechanisms of response to computerized cognitive behavioral therapy for cocaine dependence in a randomized clinical trial.
10/2017Comparable efficacy of behavioral and pharmacological treatments among African American and White cocaine users.
1/2017Functional neural changes following behavioral therapies and disulfiram for cocaine dependence.
10/2016Emotion regulation strategies in individuals with cocaine use disorder maintained on methadone.
10/2016Just showing up is not enough: Homework adherence and outcome in cognitive-behavioral therapy for cocaine dependence.
9/2016Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response.
3/2016A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kathleen M Carroll Research Topics

Disease

42Substance-Related Disorders (Drug Abuse)
01/2022 - 09/2002
25Cocaine-Related Disorders (Cocaine Addiction)
01/2019 - 02/2004
17Opioid-Related Disorders (Opiate Addiction)
09/2020 - 02/2002
12Alcoholism (Alcohol Abuse)
01/2020 - 01/2002
6Marijuana Abuse (Cannabis Abuse)
07/2014 - 12/2002
4Cognitive Dysfunction
11/2018 - 04/2010
2Tobacco Use Disorder (Nicotine Dependence)
11/2018 - 10/2009
2Gambling (Pathological Gambling)
01/2018 - 03/2017
2Pain (Aches)
09/2014 - 07/2013
2Marijuana Use
07/2013 - 07/2012
1Psychomotor Disorders
01/2020
1Anhedonia
11/2019
1Nausea
11/2018
1Alzheimer Disease (Alzheimer's Disease)
11/2018
1Anxiety Disorders (Anxiety Disorder)
10/2017
1Chronic Pain
07/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
06/2014
1Antisocial Personality Disorder (Antisocial Personality)
07/2012
1Mental Disorders (Mental Disorder)
08/2011
1Dementia (Dementias)
02/2011
1Leukemia
11/2010
1Mood Disorders (Mood Disorder)
11/2004
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2004
1Psychotic Disorders (Schizoaffective Disorder)
07/2004

Drug/Important Bio-Agent (IBA)

25Cocaine (Cocaine HCl)IBA
01/2021 - 02/2004
17Pharmaceutical PreparationsIBA
12/2020 - 05/2003
14Opioid Analgesics (Opioids)IBA
01/2021 - 02/2005
12Methadone (Dolophine)FDA LinkGeneric
01/2021 - 04/2004
8Disulfiram (Antabuse)FDA Link
01/2017 - 03/2004
6Galantamine (Galanthamine)FDA LinkGeneric
09/2020 - 02/2011
5Buprenorphine (Subutex)FDA LinkGeneric
08/2019 - 02/2005
3Illicit Drugs (Recreational Drugs)IBA
10/2020 - 01/2008
3Indicators and Reagents (Reagents)IBA
01/2020 - 01/2016
3Naloxone Drug Combination BuprenorphineFDA Link
01/2019 - 07/2014
2NicotineFDA Link
01/2022 - 10/2009
2Cholinergic Agents (Cholinergics)IBA
11/2018 - 04/2010
2Naltrexone (ReVia)FDA LinkGeneric
11/2018 - 02/2002
2Heroin (Diamorphine)IBA
05/2015 - 07/2014
22- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA
12/2014 - 04/2014
2trans-crotonin (CTN)IBA
03/2012 - 09/2002
2N-nitrosoiminodiacetic acidIBA
03/2012 - 05/2007
24-toluenesulfonyl fluoride (TSF)IBA
01/2007 - 11/2006
1Biological ProductsIBA
01/2020
1Modafinil (Provigil)FDA Link
01/2016
1Rivastigmine (Exelon)FDA LinkGeneric
01/2016
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2016
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2016
1Biological FactorsIBA
08/2015
1Prescription DrugsIBA
07/2013
14-aminospiroperidolIBA
07/2012
1Environmental BiomarkersIBA
04/2012
1AcetylcholinesteraseIBA
02/2011
1Immunoglobulin E (IgE)IBA
11/2010
1AsparagineIBA
11/2010
1Threonine (L-Threonine)FDA Link
11/2010
1Cycloserine (Seromycin)FDA Link
10/2009
1N-Methylaspartate (NMDA)IBA
10/2009
1Narcotics (Narcotic Analgesics)IBA
02/2005
1Cytochrome P-450 CYP3AIBA
09/2004
1EnzymesIBA
09/2004
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2004
1Cholinergic Antagonists (Anticholinergics)IBA
07/2004
1Opiate AlkaloidsIBA
04/2004
1Medical MarijuanaIBA
12/2002

Therapy/Procedure

29Therapeutics
01/2017 - 01/2002
4Drug Therapy (Chemotherapy)
01/2020 - 10/2005
2Aftercare (After-Treatment)
01/2020 - 05/2012
1Cognitive Training
09/2016
1Pain Management
09/2014
1Computer-Assisted Therapy (Therapy, Computer Assisted)
08/2011
1Self Administration (Administration, Self)
10/2009